Big names, big dollars back Mahzi, a Peninsula drug startup targeting rare genetic brain disorders

The 10-employee company, including veterans of rare disease drug developer Ultragenyx Pharmaceutical, has gathered $47.3 million.

Source: bizjournals.com Health Care:Physician Practices headlines - November 29, 2022 Category: American Health Authors: Ron Leuty Source Type: news